521 related articles for article (PubMed ID: 36911732)
1. The effects of microglia-associated neuroinflammation on Alzheimer's disease.
Wang C; Zong S; Cui X; Wang X; Wu S; Wang L; Liu Y; Lu Z
Front Immunol; 2023; 14():1117172. PubMed ID: 36911732
[TBL] [Abstract][Full Text] [Related]
2. Zinc utilization by microglia in Alzheimer's disease.
Shippy DC; Oliai SF; Ulland TK
J Biol Chem; 2024 May; 300(5):107306. PubMed ID: 38648940
[TBL] [Abstract][Full Text] [Related]
3. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
Elife; 2020 Jun; 9():. PubMed ID: 32510331
[TBL] [Abstract][Full Text] [Related]
4. The role of innate immune responses and neuroinflammation in amyloid accumulation and progression of Alzheimer's disease.
Webers A; Heneka MT; Gleeson PA
Immunol Cell Biol; 2020 Jan; 98(1):28-41. PubMed ID: 31654430
[TBL] [Abstract][Full Text] [Related]
5. Glial Cell-Mediated Neuroinflammation in Alzheimer's Disease.
Al-Ghraiybah NF; Wang J; Alkhalifa AE; Roberts AB; Raj R; Yang E; Kaddoumi A
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142483
[TBL] [Abstract][Full Text] [Related]
6. Microglia, neuroinflammation, and beta-amyloid protein in Alzheimer's disease.
Cai Z; Hussain MD; Yan LJ
Int J Neurosci; 2014 May; 124(5):307-21. PubMed ID: 23930978
[TBL] [Abstract][Full Text] [Related]
7. Microglial activation occurs late during preclinical Alzheimer's disease.
Streit WJ; Braak H; Del Tredici K; Leyh J; Lier J; Khoshbouei H; Eisenlöffel C; Müller W; Bechmann I
Glia; 2018 Dec; 66(12):2550-2562. PubMed ID: 30417428
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-146a switches microglial phenotypes to resist the pathological processes and cognitive degradation of Alzheimer's disease.
Liang C; Zou T; Zhang M; Fan W; Zhang T; Jiang Y; Cai Y; Chen F; Chen X; Sun Y; Zhao B; Wang Y; Cui L
Theranostics; 2021; 11(9):4103-4121. PubMed ID: 33754051
[TBL] [Abstract][Full Text] [Related]
9. Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?
Leng F; Edison P
Nat Rev Neurol; 2021 Mar; 17(3):157-172. PubMed ID: 33318676
[TBL] [Abstract][Full Text] [Related]
10. Cerebrospinal Fluid Markers of Alzheimer's Disease Pathology and Microglial Activation are Associated with Altered White Matter Microstructure in Asymptomatic Adults at Risk for Alzheimer's Disease.
Melah KE; Lu SY; Hoscheidt SM; Alexander AL; Adluru N; Destiche DJ; Carlsson CM; Zetterberg H; Blennow K; Okonkwo OC; Gleason CE; Dowling NM; Bratzke LC; Rowley HA; Sager MA; Asthana S; Johnson SC; Bendlin BB
J Alzheimers Dis; 2016; 50(3):873-86. PubMed ID: 26836182
[TBL] [Abstract][Full Text] [Related]
11. Relationship between ubiquilin-1 and BACE1 in human Alzheimer's disease and APdE9 transgenic mouse brain and cell-based models.
Natunen T; Takalo M; Kemppainen S; Leskelä S; Marttinen M; Kurkinen KMA; Pursiheimo JP; Sarajärvi T; Viswanathan J; Gabbouj S; Solje E; Tahvanainen E; Pirttimäki T; Kurki M; Paananen J; Rauramaa T; Miettinen P; Mäkinen P; Leinonen V; Soininen H; Airenne K; Tanzi RE; Tanila H; Haapasalo A; Hiltunen M
Neurobiol Dis; 2016 Jan; 85():187-205. PubMed ID: 26563932
[TBL] [Abstract][Full Text] [Related]
12. Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer's disease.
Streit WJ; Braak H; Xue QS; Bechmann I
Acta Neuropathol; 2009 Oct; 118(4):475-85. PubMed ID: 19513731
[TBL] [Abstract][Full Text] [Related]
13. Tau and neuroinflammation in Alzheimer's disease: interplay mechanisms and clinical translation.
Chen Y; Yu Y
J Neuroinflammation; 2023 Jul; 20(1):165. PubMed ID: 37452321
[TBL] [Abstract][Full Text] [Related]
14. Microglial cathepsin E plays a role in neuroinflammation and amyloid β production in Alzheimer's disease.
Xie Z; Meng J; Kong W; Wu Z; Lan F; Narengaowa ; Hayashi Y; Yang Q; Bai Z; Nakanishi H; Qing H; Ni J
Aging Cell; 2022 Mar; 21(3):e13565. PubMed ID: 35181976
[TBL] [Abstract][Full Text] [Related]
15. Spermidine reduces neuroinflammation and soluble amyloid beta in an Alzheimer's disease mouse model.
Freitag K; Sterczyk N; Wendlinger S; Obermayer B; Schulz J; Farztdinov V; Mülleder M; Ralser M; Houtman J; Fleck L; Braeuning C; Sansevrino R; Hoffmann C; Milovanovic D; Sigrist SJ; Conrad T; Beule D; Heppner FL; Jendrach M
J Neuroinflammation; 2022 Jul; 19(1):172. PubMed ID: 35780157
[TBL] [Abstract][Full Text] [Related]
16. The contribution of neuroinflammation to amyloid toxicity in Alzheimer's disease.
Minter MR; Taylor JM; Crack PJ
J Neurochem; 2016 Feb; 136(3):457-74. PubMed ID: 26509334
[TBL] [Abstract][Full Text] [Related]
17. Identification and therapeutic modulation of a pro-inflammatory subset of disease-associated-microglia in Alzheimer's disease.
Rangaraju S; Dammer EB; Raza SA; Rathakrishnan P; Xiao H; Gao T; Duong DM; Pennington MW; Lah JJ; Seyfried NT; Levey AI
Mol Neurodegener; 2018 May; 13(1):24. PubMed ID: 29784049
[TBL] [Abstract][Full Text] [Related]
18. Environmental Enrichment Potently Prevents Microglia-Mediated Neuroinflammation by Human Amyloid β-Protein Oligomers.
Xu H; Gelyana E; Rajsombath M; Yang T; Li S; Selkoe D
J Neurosci; 2016 Aug; 36(35):9041-56. PubMed ID: 27581448
[TBL] [Abstract][Full Text] [Related]
19. Targeting Microglia in Alzheimer's Disease: From Molecular Mechanisms to Potential Therapeutic Targets for Small Molecules.
Althafar ZM
Molecules; 2022 Jun; 27(13):. PubMed ID: 35807370
[TBL] [Abstract][Full Text] [Related]
20. Microglia in the Neuroinflammatory Pathogenesis of Alzheimer's Disease and Related Therapeutic Targets.
Cai Y; Liu J; Wang B; Sun M; Yang H
Front Immunol; 2022; 13():856376. PubMed ID: 35558075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
